Radar · HealthTech in Canada
Best HealthTech Companies in Canada
The 2325 best HealthTech companies in Canada in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Canopy Growth.
By Rohit KhannaTrends & Stories
2325companies tracked
$12.1Bdisclosed funding
1unicorns
564have raised
Canada's HealthTech sector is moving fast, and this directory ranks the best HealthTech companies in Canada by disclosed equity funding and recent funding momentum across 2,325 tracked companies. Total disclosed funding sits at $12.1B, which tells you the capital is real and the ecosystem is past the experimental phase.
The global market context makes that figure feel even more consequential. HealthTech is on a trajectory from roughly $908.5B in 2023 to an estimated $3,140.9B by 2033, a 13.1% CAGR according to Coherent Market Insights, driven by surging digital health adoption and rising healthcare spending. Organigram leads our directory at $504M in disclosed funding, with AlayaCare pulling $274M and CorVista at $126M. One unicorn has already cleared the billion-dollar threshold. Hot themes this quarter are telehealth platforms and digital health investments, and I'd watch that cluster closely given how telehealth funding rounds are closing globally right now. Backers like BDC, MaRS Discovery District, and Ontario Centre of Innovation are the names showing up repeatedly, which signals institutional confidence rather than speculative noise. Data privacy compliance remains a structural pressure point, but it's shaping stronger companies, not blocking them.
Sources & further reading
- Philly-area medical schools are enrolling more women and attracting more student
- Three-year medical schools show promise
- Pharmaceutical Majors Build Positions in Monoclonal Antibodies
FLIAR INTELLIGENCE · HEALTHTECH × CANADA
Our analysis of 71 HealthTech companies
$9.5b in tracked funding; 81% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
71companies analysed
81%cloud-native stacks
2025funding peak (by rounds)
1unicorns
2016median founding year
538kcombined LinkedIn audience
39%of audience held by top 3
8companies hiring publicly (12 mo)
Ranked: Best HealthTech companies in Canada
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Canopy Growth Global cannabis company dedicated to improving lives through cannabis products 67Patents top 22%Funding top 24%Innovation top 32%Market top 33% All 12 signals ▾Patentstop 22% Fundingtop 24% Innovationtop 32% Markettop 33% Producttop 35% Moattop 35% Techtop 36% Newstop 37% Talenttop 45% Globaltop 50% Growthbottom 45% Fin. healthbottom 44% Patents: 490 patents matched (strict assignee match) · 181 filings since 2022 vs 307 in 2017-21 Funding: Raised $4.8B across 9 rounds · 9 rounds over 10 yrs (0.9/yr) rank vs industry peers · Fliar Intelligence Index 67/100 | $4.8B | 29 mo ago | Public | 170 | Mark Zekulin Co-Founder | 35 signals ▼35% Earnings · M&A · Board | 490 patents Cannabinoid-derived pharmaceuticals, water‑soluble formulations, vaporizer devices, mildew‑resistant cannabis strains | 2 launchs · 2 expansions |
| 2 | WELL Health Technologies Corp Provider of EMR and virtual care tools for providers 53Funding top 22%Market top 31%Product top 35%News top 43% All 11 signals ▾Fundingtop 22% Markettop 31% Producttop 35% Newstop 43% Fin. healthtop 43% Techtop 44% Moattop 48% Talentbottom 49% Growthbottom 42% Innovationbottom 37% Globalbottom 37% Funding: Raised $839M across 10 rounds · 10 rounds over 8 yrs (1.2/yr) Market: 1,710 employees (top 3% of HealthTech) · Revenue ~$106M rank vs industry peers · Fliar Intelligence Index 53/100 | $839M | 28 mo ago | Public | 1,710 | Hamed Shahbazi Founder & CEO & Chairman | 10 signals ▼82% Earnings · Lawsuit | — | 1 partnership · 2 awards |
| 3 | Organigram Global cannabis leader driving innovation, operational excellence, and shaping the industry 72Funding top 19%Product top 24%News top 35%Tech top 37% All 11 signals ▾Fundingtop 19% Producttop 24% Newstop 35% Techtop 37% Innovationtop 38% Growthtop 38% Patentstop 38% Markettop 41% Moattop 42% Talenttop 42% Globalbottom 39% Funding: Raised $504M across 14 rounds · 14 rounds over 12 yrs (1.2/yr) Product: 3 product launch events in 12 mo · 10 distinct product lines rank vs industry peers · Fliar Intelligence Index 72/100 | $504M | 15 mo ago | Public | 923 | Icd Beena Goldenberg Chief Executive Officer | 30 signals Earnings · M&A · Leadership | 10 patents Cannabinoid emulsions and buccal delivery formulations for oral and topical use | — |
| 4 | AlayaCare Provider of cloud based platform for home healthcare practitioners 76Funding top 13%Customers top 27%Growth top 28%Moat top 31% All 12 signals ▾Fundingtop 13% Customerstop 27% Growthtop 28% Moattop 31% Innovationtop 34% Producttop 35% Techtop 38% AItop 45% Talentbottom 49% Marketbottom 48% Globalbottom 37% Newsbottom 24% Funding: Raised $274M across 10 rounds · 10 rounds over 11 yrs (0.9/yr) Customers: Play-Store rating 4.20★ across 1,946 ratings (3 apps) · Review volume +16% in 6 mo rank vs industry peers · Fliar Intelligence Index 76/100 | $274M | 3 mo ago | Series D | 92 | Adrian Schauer Founder & CEO | — | — | — |
| 5 | Fullscript Provider of a supplements dispensing platform for health practitioners 83Tech top 14%Funding top 26%Moat top 31%Growth top 35% All 10 signals ▾Techtop 14% Fundingtop 26% Moattop 31% Growthtop 35% Talenttop 38% Markettop 40% AItop 45% Producttop 46% Globalbottom 37% Newsbottom 21% Tech: 63 technologies across 8/8 capability areas · Cloud: Amazon Ses, Amazon Web Services Funding: Raised $265M across 2 rounds · 2 rounds over 7 yrs (0.3/yr) rank vs industry peers · Fliar Intelligence Index 83/100 | $265M | 13 mo ago | Series B | 251 | Chris Wise Co-Founder | — | — | 2 launchs |
| 6 | League Provider of SaaS based digital platform to manage employee health benefits 80Tech top 18%Funding top 23%Innovation top 27%Patents top 27% All 12 signals ▾Techtop 18% Fundingtop 23% Innovationtop 27% Patentstop 27% Moattop 31% Growthtop 35% AItop 45% Customerstop 45% Producttop 46% Marketbottom 47% Globalbottom 41% Newsbottom 37% Tech: 72 technologies across 6/8 capability areas · Cloud: Amazon Cloudfront, Amazon S3 Funding: Raised $242M across 5 rounds · 5 rounds over 12 yrs (0.4/yr) rank vs industry peers · Fliar Intelligence Index 80/100 | $242M | 15 mo ago | Series C | 136 | — | — | 18 patents AI-driven personalized content, activity recommendation, and wearable behavior analytics platforms. | 1 launch · 1 partnership |
| 7 | CorVista Provider of an AI-based cardiac health diagnosis tool for healthcare professionals 45Funding top 16%Moat top 31%AI top 45%Growth top 48% All 9 signals ▾Fundingtop 16% Moattop 31% AItop 45% Growthtop 48% Talenttop 49% Techbottom 46% Globalbottom 39% Newsbottom 38% Marketbottom 28% Funding: Raised $126M across 15 rounds · 15 rounds over 11 yrs (1.4/yr) Moat: Editorial + unicorn rating 8/10 · Soonicorn rank vs industry peers · Fliar Intelligence Index 45/100 | $126M | 8 mo ago | Series C | 19 | Adrian Lam CEO | — | — | — |
| 8 | Analytics4Life Developer of diagnostic platform using AI for cardiovascular disease assessments 57AI top 20%Funding top 31%Talent bottom 49%Global bottom 48% All 6 signals ▾AItop 20% Fundingtop 31% Talentbottom 49% Globalbottom 48% Techbottom 31% Newsbottom 27% AI: Classified as an AI company Funding: Raised $101M across 7 rounds · 7 rounds over 10 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 57/100 | $101M | 8 mo ago | Series C | — | Adrian Lam CEO & President | — | — | — |
| 9 | Nomic Provider of next-generation proteomics platform for drug discovery and protein analysis 60Funding top 27%Growth top 28%Talent top 28%Moat top 39% All 8 signals ▾Fundingtop 27% Growthtop 28% Talenttop 28% Moattop 39% Techtop 46% Globalbottom 43% Marketbottom 39% Newsbottom 18% Funding: Raised $63.0M across 2 rounds · 2 rounds over 6 yrs (0.3/yr) Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 60/100 | $63M | 21 mo ago | Series B | 43 | Jeff Munzar Co-Founder & CTO | — | — | 1 partnership |
| 10 | Smile Digital Health Provider of health data integration solutions for the healthcare industry 50Funding top 32%Market top 44%Growth top 45%Moat top 48% All 8 signals ▾Fundingtop 32% Markettop 44% Growthtop 45% Moattop 48% Talentbottom 49% Techbottom 47% Globalbottom 36% Newsbottom 18% Funding: Raised $60.5M across 3 rounds · 3 rounds over 5 yrs (0.6/yr) Market: 330 employees (top 12% of HealthTech) · Top-5,000,000 web property rank vs industry peers · Fliar Intelligence Index 50/100 | $60M | 16 mo ago | Series B | 330 | Duncan Weatherston CEO | — | — | 1 launch |
| 11 | Muse Provider of brainwave tracking devices and related premium subscription services 62Funding top 26%Tech top 30%Growth top 35%Innovation top 38% All 10 signals ▾Fundingtop 26% Techtop 30% Growthtop 35% Innovationtop 38% Producttop 39% Moattop 39% Customerstop 50% Talentbottom 49% Marketbottom 46% Globalbottom 38% Funding: Raised $41.0M across 11 rounds · 11 rounds over 14 yrs (0.8/yr) Tech: 54 technologies across 5/8 capability areas · Cloud: Cloudflare, Google Cloud rank vs industry peers · Fliar Intelligence Index 62/100 | $41M | 15 mo ago | Series C | 62 | Jean Fournier CEO | — | — | 1 award |
| 12 | ACTO Provider of an AI and SaaS-based educational platform for the life science industry 40Funding top 29%Growth top 37%Moat top 39%Product top 40% All 7 signals ▾Fundingtop 29% Growthtop 37% Moattop 39% Producttop 40% Techtop 48% Globalbottom 43% Marketbottom 29% Funding: Raised $39.5M across 3 rounds · 3 rounds over 6 yrs (0.5/yr) Growth: 1 acquisition/expansion move in 24 mo · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 40/100 | $40M | 21 mo ago | Series B | 18 | — | — | — | — |
| 13 | Flosonics Medical Developer of non-invasive hemodynamic monitoring devices 48Funding top 29%Moat top 32%Product top 35%Patents top 39% All 9 signals ▾Fundingtop 29% Moattop 32% Producttop 35% Patentstop 39% Innovationtop 42% Techtop 44% Globalbottom 43% Marketbottom 39% Newsbottom 22% Funding: Raised $39.0M across 4 rounds · 4 rounds over 8 yrs (0.5/yr) Moat: Editorial + unicorn rating 7/10 · IP moat: 22 patents rank vs industry peers · Fliar Intelligence Index 48/100 | $39M | 15 mo ago | Series C | 38 | — | — | 22 patents Wearable ultrasound flow sensing patches and dynamic fluid control systems for medical applications | 2 job openings · 2 awards |
| 14 | Orpyx Wearable devices for neuropathy patients and athletes 53Funding top 29%Growth top 35%Tech top 39%Product top 46% All 8 signals ▾Fundingtop 29% Growthtop 35% Techtop 39% Producttop 46% Talentbottom 49% Marketbottom 41% Globalbottom 37% Newsbottom 18% Funding: Raised $38.5M across 3 rounds · 3 rounds over 6 yrs (0.5/yr) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 53/100 | $39M | 20 mo ago | Series B | 89 | Breanne Everett Co-Founder & CEO | — | — | — |
| 15 | Practice Better Cloud based platform offering nutrition practice management software for wellness professionals 67Tech top 18%Funding top 31%Talent top 38%Growth top 39% All 10 signals ▾Techtop 18% Fundingtop 31% Talenttop 38% Growthtop 39% AItop 45% Producttop 46% Customersbottom 44% Marketbottom 43% Globalbottom 36% Newsbottom 21% Tech: 90 technologies across 7/8 capability areas · Cloud: Amazon Alb, Amazon Cloudfront Funding: Raised $27.0M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 67/100 | $27M | 18 mo ago | Series B | 37 | Graeme Downes Co-Founder | — | — | — |
| 16 | Felix Provider of an online pharmacy for purchasing medicines 67Tech top 24%Funding top 25%Growth top 35%Talent top 38% All 9 signals ▾Techtop 24% Fundingtop 25% Growthtop 35% Talenttop 38% Moattop 39% Producttop 46% Marketbottom 49% Globalbottom 37% Newsbottom 22% Tech: 48 technologies across 6/8 capability areas · Cloud: Amazon Alb, Amazon Cloudfront Funding: Raised $24.3M across 5 rounds · 5 rounds over 7 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 67/100 | $24M | 7 mo ago | Series C | 50 | Kyle Zien Co-Founder & CEO | — | — | 7 job openings |
| 17 | ZYUS Life Sciences Developer of cannabis-derived therapeutics for multiple indications 62News top 17%Funding top 21%Patents top 24%Growth top 25% All 10 signals ▾Newstop 17% Fundingtop 21% Patentstop 24% Growthtop 25% Moattop 32% Innovationtop 33% Talentbottom 49% Techbottom 48% Globalbottom 43% Marketbottom 39% News: 6 BI events in 12 mo (of 20 tracked, 6 types) · +200% YoY Funding: Raised $19.5M across 9 rounds · 9 rounds over 7 yrs (1.3/yr) rank vs industry peers · Fliar Intelligence Index 62/100 | $20M | 2 mo ago | Public | 51 | Brent Zettl Founder & CEO | 6 signals ▲200% Funding · Announcements | 45 patents Cannabinoid formulations for pain relief and migraine treatment | — |
| 18 | DIAGNOS AI-based eye disease detection tool for providers 48Product top 14%Funding top 24%Innovation top 34%News top 39% All 11 signals ▾Producttop 14% Fundingtop 24% Innovationtop 34% Newstop 39% AItop 45% Partnersbottom 49% Talentbottom 49% Techbottom 43% Growthbottom 42% Marketbottom 34% Globalbottom 30% Product: 6 distinct product lines · Company stage: Public Funding: Raised $18.5M across 14 rounds · 14 rounds over 8 yrs (1.8/yr) rank vs industry peers · Fliar Intelligence Index 48/100 | $19M | 6 mo ago | Public | 30 | Andre Larente CEO | 9 signals ▼55% Funding · Contracts | — | — |
| 19 | FluidAI AI-powered postoperative monitoring device 55Funding top 31%Talent top 38%Moat top 39%AI top 45% All 7 signals ▾Fundingtop 31% Talenttop 38% Moattop 39% AItop 45% Productbottom 48% Marketbottom 44% Globalbottom 38% Funding: Raised $18.5M across 6 rounds · 6 rounds over 8 yrs (0.8/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 55/100 | $18M | 11 mo ago | Series A | 42 | Amr Abdelgawad Co-Founder & COO | — | — | 1 job opening · 1 partnership |
| 20 | Cannara Biotech Producer of premium‐grade cannabis and cannabis‐derivative products 53Product top 14%Funding top 24%Innovation top 34%News top 34% All 9 signals ▾Producttop 14% Fundingtop 24% Innovationtop 34% Newstop 34% Moattop 39% Growthtop 47% Marketbottom 44% Techbottom 42% Globalbottom 36% Product: 5 distinct product lines · Company stage: Public Funding: Raised $17.7M across 5 rounds · 5 rounds over 8 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 53/100 | $18M | 4 mo ago | Public | 54 | — | 16 signals Earnings · Regulatory · Announcements | — | 1 partnership |
| 21 | Femto Provider of an AI-enhanced women's wellness devices and services 21Funding top 31%Talent bottom 49%Market bottom 34%Tech bottom 29% All 5 signals ▾Fundingtop 31% Talentbottom 49% Marketbottom 34% Techbottom 29% Globalbottom 25% Funding: Raised $17.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 21/100 | $17M | 15 mo ago | Public | — | Yftah Yaackov CEO | — | — | — |
| 22 | Treatment Provider of patient engagement solutions for chronic patients 37Funding top 25%Product top 28%Growth top 35%Moat top 48% All 7 signals ▾Fundingtop 25% Producttop 28% Growthtop 35% Moattop 48% Techbottom 47% Marketbottom 28% Globalbottom 25% Funding: Raised $16.5M across 8 rounds · 8 rounds over 5 yrs (1.6/yr) Product: 1 published app (300 installs) · Company stage: Public rank vs industry peers · Fliar Intelligence Index 37/100 | $16M | 10 mo ago | Public | 19 | — | — | — | — |
| 23 | Wise Docs Tech AI and cloud-based clinical documentation solutions for healthcare professionals 48Funding top 35%Growth top 35%Moat top 39%Tech top 43% All 8 signals ▾Fundingtop 35% Growthtop 35% Moattop 39% Techtop 43% Productbottom 45% Marketbottom 39% Globalbottom 36% Newsbottom 22% Funding: Raised $12.7M across 4 rounds · 4 rounds over 4 yrs (1.0/yr) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 48/100 | $13M | 16 mo ago | Series A | 42 | — | — | — | 2 launchs |
| 24 | Intrepid Labs Developer of drug formulation science to accelerate the development of therapeutics 35Market bottom 49%Funding bottom 49%Talent bottom 49%Global bottom 45% All 4 signals ▾Marketbottom 49% Fundingbottom 49% Talentbottom 49% Globalbottom 45% Funding: Raised $11.0M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 35/100 | $11M | 13 mo ago | Seed | — | Christine Allen Co-Founder and CEO | — | — | — |
| 25 | Intellijoint Developer of 3D surgical navigation tools for hip and knee replacements 50Growth top 35%Funding top 38%Tech top 50%Talent bottom 49% All 7 signals ▾Growthtop 35% Fundingtop 38% Techtop 50% Talentbottom 49% Marketbottom 48% Moatbottom 38% Globalbottom 36% Growth: Fresh capital in last 24 mo Funding: Raised $11.0M across 4 rounds · 4 rounds over 12 yrs (0.3/yr) rank vs industry peers · Fliar Intelligence Index 50/100 | $11M | 16 mo ago | Series A | 125 | Armen Bakirtzian Co-Founder and CEO | — | — | 2 partnerships |
| 26 | Synthesis A specialized medical imaging software and solutions provider 21Funding top 39%AI top 45%Tech bottom 46%Talent bottom 45% All 6 signals ▾Fundingtop 39% AItop 45% Techbottom 46% Talentbottom 45% Globalbottom 39% Marketbottom 16% Funding: Raised $9.5M across 4 rounds · 4 rounds over 2 yrs (2.0/yr) AI: Product described with: artificial intelligence rank vs industry peers · Fliar Intelligence Index 21/100 | $10M | 10 mo ago | Series A | — | Murray Reicher CEO | — | — | — |
| 27 | VentriPoint Heart analysis system 62News top 18%Product top 24%Growth top 25%Partners top 32% All 10 signals ▾Newstop 18% Producttop 24% Growthtop 25% Partnerstop 32% Fundingtop 36% Globaltop 37% Techtop 44% Innovationtop 47% Moattop 48% Marketbottom 45% News: 9 BI events in 12 mo (of 46 tracked, 7 types) · +350% YoY Product: 1 product launch event in 12 mo · 12 distinct product lines rank vs industry peers · Fliar Intelligence Index 62/100 | $9M | 16 mo ago | Public | — | — | 9 signals ▲350% Announcements · Regulatory · Funding | — | — |
| 28 | Adaptiiv Solution for developing 3D bolus for cancer patients 48Growth top 35%Funding top 38%Talent top 38%Tech top 39% All 6 signals ▾Growthtop 35% Fundingtop 38% Talenttop 38% Techtop 39% Globalbottom 36% Marketbottom 32% Growth: Fresh capital in last 24 mo Funding: Raised $8.6M across 9 rounds · 9 rounds over 10 yrs (0.9/yr) rank vs industry peers · Fliar Intelligence Index 48/100 | $9M | 10 mo ago | Series B | 30 | Alex Dunphy Co-Founder & CTO | — | — | 1 launch |
| 29 | Coral Provider of a virtual care platform that elevates women health 62Growth top 28%Talent top 38%Funding top 41%Tech top 50% All 6 signals ▾Growthtop 28% Talenttop 38% Fundingtop 41% Techtop 50% Productbottom 40% Globalbottom 36% Growth: Web rank 10,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 62/100 | $7M | 2 mo ago | Seed | — | Anna Chif Co-Founder | — | — | — |
| 30 | Rocket Doctor Developer of AI-powered software for physician support and patient care 32Funding top 28%Talent top 38%AI top 45%Tech bottom 38% All 6 signals ▾Fundingtop 28% Talenttop 38% AItop 45% Techbottom 38% Marketbottom 25% Globalbottom 25% Funding: Raised $6.6M across 4 rounds · 4 rounds over 1 yrs (4.0/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 32/100 | $7M | 4 mo ago | Public | — | William Cherniak Co-Founder & CEO | — | — | 4 partnerships |
| 31 | Eli Provider of AI-base smart devices for women to monitor reproductive health 72Innovation top 25%Growth top 25%News top 25%Tech top 31% All 11 signals ▾Innovationtop 25% Growthtop 25% Newstop 25% Techtop 31% Talenttop 38% Fundingtop 40% Moattop 44% AItop 45% Producttop 46% Globalbottom 39% Marketbottom 31% Innovation: 4 new-product events in 24 mo · Deep-tech classification: Tech Hardware Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 72/100 | $7M | 12 mo ago | Series A | 19 | Marina Rivas Co-Founder & CEO | 4 signals ▲300% New product | — | — |
| 32 | Avicanna Developer of plant-derived cannabinoid-based products 67Growth top 15%News top 24%Funding top 29%Talent top 36% All 10 signals ▾Growthtop 15% Newstop 24% Fundingtop 29% Talenttop 36% Patentstop 37% Moattop 38% Innovationtop 40% Techtop 48% Marketbottom 44% Globalbottom 39% Growth: Fresh capital in last 24 mo News: 12 BI events in 12 mo (of 54 tracked, 9 types) · +140% YoY rank vs industry peers · Fliar Intelligence Index 67/100 | $6M | 4 mo ago | Public | 80 | Aras Azadian Chief Executive Officer | 12 signals ▲140% Leadership · Earnings | 16 patents Cannabinoid pharmaceutical formulations for neurological, pain, skin, and epilepsy therapies | — |
| 33 | Ryte AI-based platform that provides data about hospitals and doctors 37Moat top 38%AI top 45%Patents top 46%Funding top 49% All 9 signals ▾Moattop 38% AItop 45% Patentstop 46% Fundingtop 49% Innovationtop 50% Talentbottom 45% Marketbottom 42% Techbottom 38% Globalbottom 36% Moat: Editorial + unicorn rating 4/10 · IP moat: 7 patents AI: Product described with: ai-based rank vs industry peers · Fliar Intelligence Index 37/100 | $6M | 15 mo ago | Series A | 95 | Saleh Almenawer Founder & CEO | — | 7 patents Expert ranking algorithms and telemedicine platforms for healthcare data analytics | — |
| 34 | COSM Provider of devices for women pelvic floor disorder 40Partners top 32%Talent top 42%AI top 45%Funding top 48% All 10 signals ▾Partnerstop 32% Talenttop 42% AItop 45% Fundingtop 48% Moattop 48% Techtop 49% Newsbottom 48% Growthbottom 47% Globalbottom 36% Marketbottom 35% Partners: 2 partnership announcements in 12 mo (2 in 24 mo) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 40/100 | $6M | 12 mo ago | Seed | 34 | Derek Sham Founder & CEO | 4 signals ▼71% Leadership | — | — |
| 35 | Molecular You Developer of personalized multi-omic digital health platform 53Talent top 28%Innovation top 31%Patents top 31%Moat top 32% All 9 signals ▾Talenttop 28% Innovationtop 31% Patentstop 31% Moattop 32% Techtop 37% Fundingtop 47% Productbottom 48% Globalbottom 36% Marketbottom 33% Talent: Analyst team rating 4/5 Innovation: 24 patents (top 39% of patent-holders) · 19 filings since 2022 vs 5 in 2017-21 rank vs industry peers · Fliar Intelligence Index 53/100 | $5M | 9 mo ago | Series A | 28 | — | — | 24 patents Molecular diagnostics and personalized therapeutics for pancreatic cancer, Alzheimer's, autism. | 1 partnership |
| 36 | FLiiP SaaS-driven business management solution for wellness & fitness centers 45Growth top 33%Funding top 37%Tech top 42%Talent bottom 49% All 7 signals ▾Growthtop 33% Fundingtop 37% Techtop 42% Talentbottom 49% Productbottom 40% Globalbottom 36% Marketbottom 34% Growth: Web rank 10,000,000 → 5,000,000 YoY · App-install growth +30% YoY Funding: Raised $4.7M across 2 rounds · 2 rounds over 1 yrs (2.0/yr) rank vs industry peers · Fliar Intelligence Index 45/100 | $5M | 8 mo ago | Seed | — | David Bourbonniere Founder & CEO | — | — | — |
| 37 | Ai4eyes Developer of an AI-powered platform for eye care and diagnostics 45Funding top 44%AI top 45%Talent bottom 49%Global bottom 25% All 4 signals ▾Fundingtop 44% AItop 45% Talentbottom 49% Globalbottom 25% Funding: Raised $4.7M across 2 rounds · 2 rounds over 1 yrs (2.0/yr) AI: Product described with: ai-powered rank vs industry peers · Fliar Intelligence Index 45/100 | $5M | 5 mo ago | Seed | — | Henry Reis Md Co-Founder | — | — | 1 partnership · 1 award |
| 38 | AI ML Innovations Provider of an AI and SaaS-based digital health monitoring platform and device for healthcare providers 42Patents top 19%Innovation top 22%AI top 30%Moat top 32% All 12 signals ▾Patentstop 19% Innovationtop 22% AItop 30% Moattop 32% Producttop 35% Fundingtop 37% Partnerstop 37% Newstop 43% Growthtop 45% Globalbottom 37% Techbottom 24% Marketbottom 18% Patents: 48 patents matched (strict assignee match) · 12 filings since 2022 vs 7 in 2017-21 Innovation: 48 patents (top 22% of patent-holders) · 12 filings since 2022 vs 7 in 2017-21 rank vs industry peers · Fliar Intelligence Index 42/100 | $4M | 14 mo ago | Public | 3 | — | 13 signals ▼78% Funding · Announcements · Contracts | 48 patents Patents concentrated in electrical & electronics | — |
| 39 | Future Fertility Provider of predictive image analysis tool for IVF clinics 40AI top 28%Growth top 35%Funding top 42%Moat top 45% All 10 signals ▾AItop 28% Growthtop 35% Fundingtop 42% Moattop 45% Patentstop 46% Innovationbottom 46% Marketbottom 36% Globalbottom 36% Newsbottom 22% Techbottom 18% AI: Holds AI/ML patents (G06N-family CPC) · Product described with: ai-based Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 40/100 | $4M | 1 mo ago | Series A | 29 | — | — | 4 patents Patents concentrated in computing, sensing & instrumentation | 1 partnership |
| 40 | ProteinQure Provider of computational protein drug design platform 53Talent top 28%AI top 30%Innovation top 36%Product top 36% All 10 signals ▾Talenttop 28% AItop 30% Innovationtop 36% Producttop 36% Moattop 37% Patentstop 38% Fundingtop 46% Techbottom 45% Globalbottom 40% Marketbottom 29% Talent: Analyst team rating 4/5 · 4 named leaders on record AI: Classified as an AI company · Product described with: artificial intelligence rank vs industry peers · Fliar Intelligence Index 53/100 | $4M | 12 mo ago | Series A | 18 | Tomas Babej Cofounder and Chief Technology Officer | — | 9 patents Protein therapeutics targeting the sortilin receptor and natriuretic peptide delivery systems | 2 job openings |
| 41 | MedMe Health Cloud based pharmacy management software for professionals 42Growth top 35%Funding top 42%Moat top 48%Tech bottom 49% All 8 signals ▾Growthtop 35% Fundingtop 42% Moattop 48% Techbottom 49% Talentbottom 49% Marketbottom 36% Globalbottom 36% Newsbottom 22% Growth: Fresh capital in last 24 mo Funding: Raised $3.7M across 4 rounds · 4 rounds over 6 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 42/100 | $4M | 9 mo ago | Seed | 31 | Nicholas Hui Co-Founder & Chief Product Officer | — | — | — |
| 42 | ViewsML AI-powered platform for drug development and companion diagnostics 21AI top 45%Funding top 46%Talent bottom 49%Global bottom 36% All 5 signals ▾AItop 45% Fundingtop 46% Talentbottom 49% Globalbottom 36% Marketbottom 21% AI: Product described with: ai-powered Funding: Raised $3.6M across 1 rounds · 1 rounds over 2 yrs (0.5/yr) rank vs industry peers · Fliar Intelligence Index 21/100 | $4M | 1 mo ago | Seed | 8 | Kenneth To CEO | — | — | 1 award |
| 43 | Cobionix Manufacturer of a robot for performing routine tasks 50AI top 15%Moat top 31%Growth top 35%Patents top 35% All 10 signals ▾AItop 15% Moattop 31% Growthtop 35% Patentstop 35% Innovationtop 36% Talenttop 38% Fundingbottom 46% Techbottom 40% Globalbottom 36% Marketbottom 23% AI: Holds AI/ML patents (G06N-family CPC) Moat: Editorial + unicorn rating 7/10 · IP moat: 15 patents rank vs industry peers · Fliar Intelligence Index 50/100 | $3M | 11 mo ago | Seed | 14 | Tim Lasswell Co-Founder | — | 15 patents Autonomous robotic platforms for medical imaging, transport, and structural sensing with AI control | — |
| 44 | Mystoria Provider of a platform for reproductive health tracking and support 60Growth top 35%Talent top 38%Funding top 41%Tech top 42% All 6 signals ▾Growthtop 35% Talenttop 38% Fundingtop 41% Techtop 42% Productbottom 40% Globalbottom 33% Growth: Fresh capital in last 24 mo Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 60/100 | $2M | 1 mo ago | Seed | — | Holly Tiessen Co-Founder & CRO | — | — | 1 job opening · 1 partnership |
| 45 | PanGenomic Online teleconsultation platform for the patients and healthcare providers 24Talent top 28%Product top 35%Funding top 45%Growth bottom 48% All 7 signals ▾Talenttop 28% Producttop 35% Fundingtop 45% Growthbottom 48% Globalbottom 29% Newsbottom 28% Marketbottom 24% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Product: 0 product launch events in 12 mo · Company stage: Public rank vs industry peers · Fliar Intelligence Index 24/100 | $2M | 5 mo ago | Public | 10 | Robert Nygren Co-Founder and Executive Chair | — | — | — |
| 46 | Radwave Tech Provider of tracking system for biomedical devices 8Funding top 47%Global bottom 37%Market bottom 22% All 3 signals ▾Fundingtop 47% Globalbottom 37% Marketbottom 22% Funding: Raised $1.5M across 3 rounds · 3 rounds over 5 yrs (0.6/yr) Global: Investors from 1 country beyond Canada rank vs industry peers · Fliar Intelligence Index 8/100 | $1M | 8 mo ago | Seed | 9 | — | — | — | — |
| 47 | Andira Digital pharmacotherapeutic platform for providers 21Funding top 50%Talent bottom 49%Market bottom 37%Global bottom 29% All 4 signals ▾Fundingtop 50% Talentbottom 49% Marketbottom 37% Globalbottom 29% Funding: Raised $1.4M across 5 rounds · 5 rounds over 4 yrs (1.2/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 21/100 | $1M | 3 mo ago | Seed | — | Dana Lambert Chief Executive Officer | — | — | — |
| 48 | Steadiwear Designer & manufacturer of healthcare gloves 29Growth top 35%Moat top 38%Tech top 42%Funding bottom 49% All 10 signals ▾Growthtop 35% Moattop 38% Techtop 42% Fundingbottom 49% Talentbottom 49% Productbottom 47% Innovationbottom 40% Globalbottom 39% Patentsbottom 37% Marketbottom 17% Growth: Fresh capital in last 24 mo Moat: Editorial + unicorn rating 4/10 · IP moat: 8 patents rank vs industry peers · Fliar Intelligence Index 29/100 | $1M | 8 mo ago | Seed | 6 | Mark Elias Co-Founder & CEO | — | 8 patents Wearable tremor‑damping devices for involuntary hand motion control in medical applications | — |
| 49 | Dentronic Developer of robotic arm designed to automate dental assistive tasks 50Talent top 45%Global bottom 48%Funding bottom 47% All 3 signals ▾Talenttop 45% Globalbottom 48% Fundingbottom 47% Talent: 2 named leaders on record Global: Investors from 1 country beyond Canada rank vs industry peers · Fliar Intelligence Index 50/100 | $1M | 3 mo ago | Seed | — | Soy Choi Co-Founder | — | — | — |
| 50 | StokedBio Developer of therapeutics based on AI technology 45Talent top 28%AI top 45%Funding top 46%Market bottom 37% All 5 signals ▾Talenttop 28% AItop 45% Fundingtop 46% Marketbottom 37% Globalbottom 29% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated AI: Product described with: ai-based rank vs industry peers · Fliar Intelligence Index 45/100 | $366K | 1 mo ago | Seed | — | Chris Sinclair Co-Founder | — | — | — |
Top 12 HealthTech companies in Canada
#1
Series D · Toronto, Ontario · founded 2014 · 92 employees$274.1Mraised▾
Series D · Toronto, Ontario · founded 2014 · 92 employees
Alayacare offers a cloud-based software platform for home healthcare practitioners. The platform features clinical documentation, back-office functionality, patient and family portals, remote patient monitoring, telehealth, and mobile care worker apps. It also helps in analyzing wearable devices to fetch patient data for processing through machine learning technology by giving real-time insights for the care professionals.
Fliar Intelligence Index™ 76how this company ranks against its industry peers
Funding
top 13%Customers
top 27%Growth
top 28%Moat
top 31%Innovation
top 34%Product
top 35%Funding: Raised $274M across 10 rounds · 10 rounds over 11 yrs (0.9/yr) · Last round Conventional Debt (Feb 2026)
Customers: Play-Store rating 4.20★ across 1,946 ratings (3 apps) · Review volume +16% in 6 mo · Marquee-customer mentions: top 17% of tracked companies
Growth: Headcount 56 → 92 (+64%) across vintages · App-install growth +32% YoY · Fresh capital in last 24 mo
Audience (LinkedIn): 64k LinkedIn followers — 11.9% of this cohort's audience
Funding rounds
- Feb 2026Conventional Debt$50M
- Jun 2021Series D$182M
- Aug 2020Conventional Debt$11.4M
- Jan 2020Series C$36.8M
Founders & team
Investors
Inovia Capital, CDPQ, Invest Quebec, Fonds Innovexport, Canadian Imperial Bank of Commerce, Generation Investment Management
Tech stack
Amazon Web ServicesApple Icloud MailBeaver BuilderBootstrapCloudflareCloudflare Bot Management
#2
Public · Saskatoon, Saskatchewan · founded 2018 · 51 employees$19.5Mraised▾
Public · Saskatoon, Saskatchewan · founded 2018 · 51 employees
Developer of cannabis-derived therapeutics for multiple indications. The company is focusing on the development of cannabinoid-based therapeutics and protein-based formulations to provide targeted relief for patients. The company's lead drug candidate is Trichomylin to alleviate chronic pain.
Fliar Intelligence Index™ 62how this company ranks against its industry peers
News
top 17%Funding
top 21%Patents
top 24%Growth
top 25%Moat
top 32%Innovation
top 33%News: 6 BI events in 12 mo (of 20 tracked, 6 types) · +200% YoY · 4 high-value events (IPO/M&A/funding/contracts) in 12 mo
Funding: Raised $19.5M across 9 rounds · 9 rounds over 7 yrs (1.3/yr) · Last round Post IPO (Mar 2026)
Patents: 45 patents matched (strict assignee match) · 26 filings since 2022 vs 19 in 2017-21 · Latest publication 2025
Audience (LinkedIn): 5k LinkedIn followers
Hiring (LinkedIn): 2 hiring posts in 12 mo (public) · hiring: Legal Counsel, Executive Administrator
Activity (LinkedIn): 1 product launches announced in 12 mo
Funding rounds
- Mar 2026Post IPO$207K
- Nov 2025Post IPO$1.1M
- Jul 2025Post IPO$233K
- Jun 2025Post IPO$182.4K
Founders & team
Investors
Keyhorse Capital, Mammoth View
Tech stack
CloudflareCloudflare Bot ManagementFont AwesomeFroala EditorGodaddyGoogle Cloud
#3
Series C · Toronto, Ontario · founded 2012 · 19 employees$126Mraised▾
Series C · Toronto, Ontario · founded 2012 · 19 employees
Provider of an AI-based cardiac health diagnosis tool for healthcare professionals. The company has designed a diagnostic tool called CorVista that has the ability to detect cardiovascular disease in patients. The AI technology used in the software analyses patients' data in order to detect diseases such as pulmonary hypertension, heart failure, or coronary artery diseases.
Fliar Intelligence Index™ 45how this company ranks against its industry peers
Funding
top 16%Moat
top 31%AI
top 45%Growth
top 48%Talent
top 49%Tech
bottom 46%Funding: Raised $126M across 15 rounds · 15 rounds over 11 yrs (1.4/yr) · Last round Series C (Oct 2025)
Moat: Editorial + unicorn rating 8/10 · Soonicorn · 9 curated direct competitors tracked
AI: Product described with: ai-based
Funding rounds
- Oct 2025Series C$550K
- Jun 2025Series C$500K
- May 2025Series C$899.2K
- Jan 2025Series C$797.7K
Founders & team
Investors
MedVenture Partners, Bioworld Ventures, JLABS, G Ventures
Tech stack
CloudflareCloudflare Browser InsightsGoogle AnalyticsHstsJqueryJsdelivr
#4
Series C · Toronto, Ontario · founded 2012$100.7Mraised▾
Series C · Toronto, Ontario · founded 2012
Developer of diagnostic platform using AI for cardiovascular disease assessments. The platform CorVista System automates clinical data collection and diagnostic review, providing clinicians with actionable assessments at the point of care. The technology leverages machine-learned models designed for diagnostic performance, with a focus on multiple cardiovascular conditions. The system gathers heart signals and transmits the data to a secure cloud platform for processing.
Fliar Intelligence Index™ 57how this company ranks against its industry peers
AI
top 20%Funding
top 31%Talent
bottom 49%Global
bottom 48%Tech
bottom 31%News
bottom 27%AI: Classified as an AI company
Funding: Raised $101M across 7 rounds · 7 rounds over 10 yrs (0.7/yr) · Last round Series C (Oct 2025)
Talent: 1 named leader on record · 1 C-suite/founder profile curated
Funding rounds
- Oct 2025Series C$550K
- Jun 2025Series C$500K
- Jun 2024Series C$1.5M
- Aug 2022Series C$1M
Founders & team
Investors
MedVenture Partners
Tech stack
WordpressMysqlPhpGeneratepressGravity FormsGenerateblocks
#5
Public · Moncton, New Brunswick · founded 2013 · 923 employees$503.7Mraised▾
Public · Moncton, New Brunswick · founded 2013 · 923 employees
Global cannabis leader driving innovation, operational excellence, and shaping the industry. The company redefines the cannabis sector through innovative products, beloved consumer brands, and a growing international presence. They push the boundaries of cannabis cultivation and product development, using a scientific approach and cutting-edge technology to bring high-quality products to consumers. Their portfolio includes popular brands, each offering exceptional quality and unique experiences. They strategically invest in and partner with companies to extend their reach beyond Canada, bringing their products, brands, and intellectual property to new markets. They envision a future where cannabis is embraced as a mainstream consumer choice with broader market access and responsible regulation. They are adapting to the consumer of tomorrow, prioritizing experience and seeing cannabis as an alternative to traditional products. They are committed to making a positive impact in their communities through social impact initiatives.
Fliar Intelligence Index™ 72how this company ranks against its industry peers
Funding
top 19%Product
top 24%News
top 35%Tech
top 37%Innovation
top 38%Growth
top 38%Funding: Raised $504M across 14 rounds · 14 rounds over 12 yrs (1.2/yr) · Last round Post IPO (Feb 2025)
Product: 3 product launch events in 12 mo · 10 distinct product lines · Company stage: Public
News: 30 BI events in 12 mo (of 334 tracked, 13 types) · +3% YoY · 7 high-value events (IPO/M&A/funding/contracts) in 12 mo
Audience (LinkedIn): 35k LinkedIn followers — 6.4% of this cohort's audience
Funding rounds
- Feb 2025Post IPO$29M
- Aug 2024Post IPO$30.8M
- Jan 2024Post IPO$30.8M
- Mar 2021Post IPO$175M
Founders & team
Investors
BMO, FCC, British American Tobacco, Government of New Brunswick, BT DE Investments, Herbal Capital
Tech stack
AddtoanyAnimate.CssApple Icloud MailBootstrapCdnjsCloudflare
#6
Public · Montreal, Montreal · founded 2018 · 54 employees$17.7Mraised▾
Public · Montreal, Montreal · founded 2018 · 54 employees
Producer of premium‐grade cannabis and cannabis‐derivative products. The company offer a variety of organic cannabis-infused with medicinal herbs and flowers. The company offerings span dried flower, pre-rolls, hash, rosin, live resin extracts, oils, and accessories, all hang-dried, hand-trimmed, and slow-cured for potency and terpene preservation.
Fliar Intelligence Index™ 53how this company ranks against its industry peers
Product
top 14%Funding
top 24%Innovation
top 34%News
top 34%Moat
top 39%Growth
top 47%Product: 5 distinct product lines · Company stage: Public
Funding: Raised $17.7M across 5 rounds · 5 rounds over 8 yrs (0.6/yr) · Last round Post IPO (Feb 2026)
Innovation: 5 product lines
Audience (LinkedIn): 9k LinkedIn followers
Activity (LinkedIn): 1 partnerships (incl. Blue River Terps) announced in 12 mo
Funding rounds
- Feb 2026Post IPO$4.6M
- Jul 2021Post IPO$5M
- Oct 2019Conventional Debt$6M
- Jul 2019Post IPO$2.2M
Investors
FSD Pharma, Canadian Imperial Bank of Commerce, Phoenician Capital, Keiretsu Forum
Tech stack
CloudflareCloudflare Bot ManagementCore-JsElementorFormidable FormGodaddy
#7
Series B · Ottawa, Ontario · founded 1995 · 251 employees$265Mraised▾
Series B · Ottawa, Ontario · founded 1995 · 251 employees
Fullscript is a software platform for dispensing professional-grade nutraceuticals and supplements. It allows health practitioners to prescribe and dispense supplements (online or in person.) from a catalog of health products from different professional brands. Also, allows them to send personalized product recommendations directly to patients via email or SMS. The system can also be integrated with the users existing EHR system for data access.
Fliar Intelligence Index™ 83how this company ranks against its industry peers
Tech
top 14%Funding
top 26%Moat
top 31%Growth
top 35%Talent
top 38%Market
top 40%Tech: 63 technologies across 8/8 capability areas · Cloud: Amazon Ses, Amazon Web Services · Devops: Nginx, Varnish
Funding: Raised $265M across 2 rounds · 2 rounds over 7 yrs (0.3/yr) · Last round PE (May 2025)
Moat: Editorial + unicorn rating 8/10 · Soonicorn · 9 curated direct competitors tracked
Audience (LinkedIn): 25k LinkedIn followers — 4.6% of this cohort's audience
Activity (LinkedIn): 2 product launches announced in 12 mo
Funding rounds
- May 2025PE—
- Nov 2021PE$240M
- May 2019Series B$25M
Founders & team
Investors
Kayne Anderson Capital Advisors, Kayne Anderson, Snapdragon Capital Partners, HGGC, Leonard Green and Partners, VentureOut
Tech stack
AdaAmazon SesAmazon Web ServicesAppcuesApple Icloud MailCart Functionality
#8
Public · Brossard, Quebec · founded 1998 · 30 employees$18.5Mraised▾
Public · Brossard, Quebec · founded 1998 · 30 employees
AI-based eye disease detection tool for providers. The company has developed software that assists with disease diagnosis and treatment management. It has features for image processing, data analysis, early detection of diseases, and more.
Fliar Intelligence Index™ 48how this company ranks against its industry peers
Product
top 14%Funding
top 24%Innovation
top 34%News
top 39%AI
top 45%Partners
bottom 49%Product: 6 distinct product lines · Company stage: Public
Funding: Raised $18.5M across 14 rounds · 14 rounds over 8 yrs (1.8/yr) · Last round Post IPO (Dec 2025)
Innovation: 6 product lines
Funding rounds
- Dec 2025Post IPO$2.9M
- Sep 2025Post IPO$72.6K
- Feb 2025Post IPO$1.4M
- Oct 2024Post IPO$1.1M
Founders & team
Tech stack
WordpressMysqlPhpDebianAnimate.CssContact Form 7
#9
Seed · Wright-gracefield-northfield, Quebec · founded 2024$7Mraised▾
Seed · Wright-gracefield-northfield, Quebec · founded 2024
Provider of a virtual care platform that elevates women health. It offers evidence-based personalised support for perimenopause, menopause based on health assesment and track the progress.
Fliar Intelligence Index™ 62how this company ranks against its industry peers
Growth
top 28%Talent
top 38%Funding
top 41%Tech
top 50%Product
bottom 40%Global
bottom 36%Growth: Web rank 10,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Funding: Raised $7.0M across 2 rounds · 2 rounds over 1 yrs (2.0/yr) · Last round Seed (Mar 2026)
Audience (LinkedIn): 3k LinkedIn followers
Activity (LinkedIn): 1 expansions announced in 12 mo
Funding rounds
- Mar 2026Seed$2.9M
- Feb 2025Seed$4.1M
Founders & team
Investors
Brightspark Ventures, Diagram Ventures, The51, AQC Capital, Anges Quebec
Tech stack
Chart.JsContact Form 7CookieyesCore-JsFacebook PixelGoogle Analytics
#10
Series C · Toronto, Ontario · founded 2014 · 136 employees$242Mraised▾
Series C · Toronto, Ontario · founded 2014 · 136 employees
League provides a SaaS-based digital platform for employee health benefits. The platform gives employers tools to easily manage their benefits program and deliver healthcare services for employees. The web-based app gives the ability to create personal health spending accounts and tracks employee utilization. It also gives customized offerings for employees, delivered on-site by the best health professionals in the business.
Fliar Intelligence Index™ 80how this company ranks against its industry peers
Tech
top 18%Funding
top 23%Innovation
top 27%Patents
top 27%Moat
top 31%Growth
top 35%Tech: 72 technologies across 6/8 capability areas · Cloud: Amazon Cloudfront, Amazon S3 · Observability: Sentry
Funding: Raised $242M across 5 rounds · 5 rounds over 12 yrs (0.4/yr) · Last round Series C (Feb 2025)
Innovation: 18 patents (top 28% of patent-holders) · 13 filings since 2022 vs 3 in 2017-21
Audience (LinkedIn): 55k LinkedIn followers — 10.2% of this cohort's audience
Activity (LinkedIn): 1 product launches · 1 partnerships (incl. Amwell) announced in 12 mo
Funding rounds
- Feb 2025Series C—
- Feb 2022Series C$95M
- Dec 2021Series C$70M
- Oct 2019Series B—
Investors
TDM Growth Partners, Workday Ventures, BDC, Manulife, OMERS, Royal Bank of Canada
Tech stack
Amazon S3Amazon Web ServicesCloudflareCloudflare Bot ManagementCore-JsDemandbase
#11
Series C · Toronto, Ontario · founded 2019 · 50 employees$24.3Mraised▾
Series C · Toronto, Ontario · founded 2019 · 50 employees
Provider of an online pharmacy for purchasing medicines. The platform allows users to order prescribed medicines online and can get the medicines delivered to their doorstep. It offers medication for various diseases like birth control, erectile dysfunction, acne, hair loss, and many more.
Fliar Intelligence Index™ 67how this company ranks against its industry peers
Tech
top 24%Funding
top 25%Growth
top 35%Talent
top 38%Moat
top 39%Product
top 46%Tech: 48 technologies across 6/8 capability areas · Cloud: Amazon Alb, Amazon Cloudfront · Devops: Nginx
Funding: Raised $24.3M across 5 rounds · 5 rounds over 7 yrs (0.7/yr) · Last round Series C (Oct 2025)
Growth: Fresh capital in last 24 mo
Audience (LinkedIn): 15k LinkedIn followers — 2.9% of this cohort's audience
Hiring (LinkedIn): 7 hiring posts in 12 mo (public) · momentum +7 · hiring: Staff Pharmacist, Product Engineer
Funding rounds
- Oct 2025Series C$53M
- Apr 2023Series B$13.4M
- Dec 2020Series A$7.8M
- Nov 2019Seed$2.5M
Founders & team
Investors
BDC, Canadian Business Growth Fund, Whitecap Venture Partners, Mantella Venture Partners, Grassfed Ventures, H Venture Partners
Tech stack
AdrollAdroll Cmp SystemAmazon CloudfrontAmazon Web ServicesApple Icloud MailBootstrap
#12
Public · Toronto, Ontario · founded 2016 · 80 employees$5.9Mraised▾
Public · Toronto, Ontario · founded 2016 · 80 employees
Developer of plant-derived cannabinoid-based products. The company develops advanced cannabinoid formulations and delivery mechanisms for medical applications and consumer products. It markets its cannabinoid-based solutions to a range of channels and markets including derma-cosmetics, phytotherapeutics, and pharmaceutical solutions.
Fliar Intelligence Index™ 67how this company ranks against its industry peers
Growth
top 15%News
top 24%Funding
top 29%Talent
top 36%Patents
top 37%Moat
top 38%Growth: Fresh capital in last 24 mo
News: 12 BI events in 12 mo (of 54 tracked, 9 types) · +140% YoY · Top themes: Leadership, Earnings
Funding: Raised $5.9M across 19 rounds · 19 rounds over 9 yrs (2.1/yr) · Last round Post IPO (Feb 2026)
Funding rounds
- Feb 2026Post IPO$1.1M
- Jul 2025Post IPO$729.7K
- Nov 2024Post IPO$573.3K
- Aug 2024Post IPO$1.5M
Founders & team
Investors
Tasly, Orthogonal Thinker, Barn Invest
Tech stack
WordpressMysqlPhpApache Http Server
Funding & investor landscape
$12.1Btotal disclosed funding
462companies funded
1,061disclosed rounds
7rounds last 90 days
Most active investors
Notable founders
Adrian Schauer
Founder & CEO · AlayaCare
Brent Zettl
Founder & CEO · ZYUS Life Sciences
Adrian Lam
CEO · CorVista
Icd Beena Goldenberg
Chief Executive Officer · Organigram
Chris Wise
Co-Founder · Fullscript
Brad Dyment
Co-Founder @ Fullscript · Fullscript
Andre Larente
CEO · DIAGNOS
Anna Chif
Co-Founder · Coral
Fiona Lake Waslander
Co-Founder & CEO · Coral
Kyle Zien
Co-Founder & CEO · Felix
Emma Stern
Co-Founder & COO · Felix
Aras Azadian
Chief Executive Officer · Avicanna
Prism market signals · Canada · country-scoped Prism corpus, 294,048 docs
Market landscape — 10 sub-themes by coverage
Share of HealthTech coverage by sub-theme.
Regulatory-risk over time flat
Funding & growth over time
funding rising · growth rising
RESEARCH SIGNALS · Canada
How research on Digital Health is moving in Canada
A read on the academic research around Digital Health — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 2,157 Canada-affiliated papers.
research sentiment over time
200820172026
enthusiastic · positive · guarded tone
Tone is overwhelmingly optimistic and intensifying — the enthusiastic (strongly-positive) share moved 21% → 39% across 2008–2026.
top research entities
- Ministry of Health313
- University of Toronto275
- McMaster University160
- University of British Columbia137
- McGill University114
leading researchers
Jeremy Grimshaw · Anita Kothari · Ihoghosa Iyamu · Anna R. Gagliardi · John P. Hirdes · Ian D. Graham · John N. Lavis · André Kushniruk
▲
Breakthroughs178 · 8%
▲ 3%→9% share
▲3.0× share momentum0 median citations91% since 2021mostly methods-led
Health informatics breakthroughs are surging — Canadian papers rose from 3 to 37, tripling field-share to 9%.
rising sub-themes (early→recent)
- Health care3→42
- Health informatics3→37
- Public health2→22
- Wearable computer2→20
- Remote patient monitoring2→15
Newly emergingMental health 0→12 · Interoperability 0→10 · Psychological intervention 0→10
Landmark Conceptualising patient empowerment: a mixed methods study · 433 cites
◆
Advancements668 · 31%
▲ 27%→32% share
▲1.2× share momentum0 median citations86% since 2021mostly empirical
Psychological intervention advancements are intensifying — Canadian digital health papers jumped from 6 to 67 since baseline.
rising sub-themes (early→recent)
- Health care12→180
- Health informatics50→142
- Public health21→87
- Psychological intervention6→67
- Mental health2→51
Newly emergingmHealth 0→30 · Telemedicine 0→28 · MEDLINE 0→23
Landmark A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems · 3,794 cites
▼
Concerns1,013 · 47%
▼ 57%→45% share
▼0.8× share momentum2 median citations80% since 2021mostly empirical
Health informatics concern-flagged research is rising sharply — papers grew from 99 to 246 across Canadian institutions.
rising sub-themes (early→recent)
- Health care44→291
- Public health42→196
- Health informatics99→246
- Nursing research47→147
- Health administration81→180
Newly emergingPandemic 0→32 · Interoperability 0→31 · Telehealth 0→27
Landmark The future of digital health with federated learning · 2,258 cites
RESEARCH HOTSPOTS · Canada
Where digital health is researched across Canada
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Toronto329 · +0.11
Montreal246 · +0.11
Waterloo/Hamilton211 · +0.01
Vancouver169 · +0.06
Edmonton/Calgary165 · +0.12
Ottawa/Kingston157 · +0.11
PATENT SIGNAL · Canada
Who's filing medical devices patents in Canada
Canada medical devices patent filing is cooling — 23,091 filings from 8,000 assignees (2016–2025), led by Medtronic Cryocath, Trudell Medical INT, UNIV Health Network; annual filings 2103→2001.
23,091 filings8,000 assigneespeak 2671/yr2016–2025
filing momentum (YoY 2016–2025)
top patent filers
- Medtronic Cryocath802
- Trudell Medical INT750
- UNIV Health Network587
- Orthosoft474
- Kardium452
- Baylis Medical420
- Sunnybrook RES INST410
- Titan MED390
Common questions
How many HealthTech companies are there in Canada?
Radar tracks 2325 indexable HealthTech companies headquartered in Canada that meet our profile-completeness bar.
What is the total funding raised by HealthTech companies in Canada?
The HealthTech companies in Canada on this list have raised a combined $12.1B in disclosed equity funding across 462 funded companies.
Which is the highest-funded HealthTech company in Canada?
Canopy Growth is the highest-funded HealthTech company in Canada, with $4.8B in disclosed equity funding.
How many HealthTech companies in Canada are funded?
462 of the 2325 HealthTech companies in Canada on this list have disclosed at least one equity funding round.
How many HealthTech unicorns are there in Canada?
1 HealthTech company in Canada on this list is valued at $1B or more.
Who are the top investors in Canada HealthTech companies?
The most active investors in Canada HealthTech companies on this list include Ontario Centre of Innovation, Accelerator Centre, BDC, MaRS Discovery District, Techstars.
Rohit KhannaTrends & Stories
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.